163 related articles for article (PubMed ID: 36745032)
21. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
Sheraz M; Cheng J; Tang L; Chang J; Guo JT
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
[TBL] [Abstract][Full Text] [Related]
22. PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.
Zhang W; Chen J; Wu M; Zhang X; Zhang M; Yue L; Li Y; Liu J; Li B; Shen F; Wang Y; Bai L; Protzer U; Levrero M; Yuan Z
Hepatology; 2017 Aug; 66(2):398-415. PubMed ID: 28236308
[TBL] [Abstract][Full Text] [Related]
23. TAGLN2, a novel regulator involved in Hepatitis B virus transcription and replication.
Yu Y; He Z; Cao Y; Tang H; Huang F
Biochem Biophys Res Commun; 2016 Sep; 477(4):1051-1058. PubMed ID: 27402267
[TBL] [Abstract][Full Text] [Related]
24. Lost Small Envelope Protein Expression from Naturally Occurring PreS1 Deletion Mutants of Hepatitis B Virus Is Often Accompanied by Increased HBx and Core Protein Expression as Well as Genome Replication.
Fu S; Zhang J; Yuan Q; Wang Q; Deng Q; Li J; Xia N; Wang Y; Wen Y; Tong S
J Virol; 2021 Jun; 95(14):e0066021. PubMed ID: 33910956
[TBL] [Abstract][Full Text] [Related]
25. Involvement of Host ATR-CHK1 Pathway in Hepatitis B Virus Covalently Closed Circular DNA Formation.
Luo J; Luckenbaugh L; Hu H; Yan Z; Gao L; Hu J
mBio; 2020 Feb; 11(1):. PubMed ID: 32071277
[TBL] [Abstract][Full Text] [Related]
26. HBV X protein mutations affect HBV transcription and association of histone-modifying enzymes with covalently closed circular DNA.
Chong CK; Cheng CYS; Tsoi SYJ; Huang FY; Liu F; Fung J; Seto WK; Lai KK; Lai CL; Yuen MF; Wong DK
Sci Rep; 2020 Jan; 10(1):802. PubMed ID: 31964944
[TBL] [Abstract][Full Text] [Related]
27. Intracellular antibody targeting HBx suppresses invasion and metastasis in hepatitis B virus-related hepatocarcinogenesis via protein phosphatase 2A-B56γ-mediated dephosphorylation of protein kinase B.
Che L; Du ZB; Wang WH; Wu JS; Han T; Chen YY; Han PY; Lei Z; Chen XX; He Y; Xu L; Lin X; Lin ZN; Lin YC
Cell Prolif; 2022 Nov; 55(11):e13304. PubMed ID: 35811356
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B Virus Core Protein Is Not Required for Covalently Closed Circular DNA Transcriptional Regulation.
Zhong Y; Wu C; Xu Z; Teng Y; Zhao L; Zhao K; Wang J; Wang W; Zhan Q; Zhu C; Chen X; Liang K; Cheng X; Xia Y
J Virol; 2022 Nov; 96(21):e0136222. PubMed ID: 36226986
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B Virus X Protein Is Stabilized by the Deubiquitinating Enzyme VCPIP1 in a Ubiquitin-Independent Manner by Recruiting the 26S Proteasome Subunit PSMC3.
Wu Q; Zhang L; Xu X; Zhang Y; Shi J; Lin X; Chen W
J Virol; 2022 Jul; 96(13):e0061122. PubMed ID: 35695579
[TBL] [Abstract][Full Text] [Related]
30. Targeting Hepatitis B Virus Covalently Closed Circular DNA and Hepatitis B Virus X Protein: Recent Advances and New Approaches.
Prescott NA; Bram Y; Schwartz RE; David Y
ACS Infect Dis; 2019 Oct; 5(10):1657-1667. PubMed ID: 31525994
[TBL] [Abstract][Full Text] [Related]
31. HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase.
Rivière L; Gerossier L; Ducroux A; Dion S; Deng Q; Michel ML; Buendia MA; Hantz O; Neuveut C
J Hepatol; 2015 Nov; 63(5):1093-102. PubMed ID: 26143443
[TBL] [Abstract][Full Text] [Related]
32. Anti-HBV efficacy of combined siRNAs targeting viral gene and heat shock cognate 70.
Bian Z; Xiao A; Cao M; Liu M; Liu S; Jiao Y; Yan W; Qi Z; Zheng Z
Virol J; 2012 Nov; 9():275. PubMed ID: 23158906
[TBL] [Abstract][Full Text] [Related]
33. Role of hepatitis B core protein in HBV transcription and recruitment of histone acetyltransferases to cccDNA minichromosome.
Chong CK; Cheng CYS; Tsoi SYJ; Huang FY; Liu F; Seto WK; Lai CL; Yuen MF; Wong DK
Antiviral Res; 2017 Aug; 144():1-7. PubMed ID: 28499864
[TBL] [Abstract][Full Text] [Related]
34. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
35. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus X protein promotes hepatocarcinogenesis via the activation of HMGA2/STC2 signaling to counteract oxidative stress-induced cell death.
Huang FY; Wong DK; Mak LY; Cheung TT; Seto WK; Yuen MF
Carcinogenesis; 2022 Aug; 43(7):671-681. PubMed ID: 35353897
[TBL] [Abstract][Full Text] [Related]
37. Sirtuin 2 Isoform 1 Enhances Hepatitis B Virus RNA Transcription and DNA Synthesis through the AKT/GSK-3β/β-Catenin Signaling Pathway.
Piracha ZZ; Kwon H; Saeed U; Kim J; Jung J; Chwae YJ; Park S; Shin HJ; Kim K
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111572
[TBL] [Abstract][Full Text] [Related]
38. Peroxiredoxin 1, a Novel HBx-Interacting Protein, Interacts with Exosome Component 5 and Negatively Regulates Hepatitis B Virus (HBV) Propagation through Degradation of HBV RNA.
Deng L; Gan X; Ito M; Chen M; Aly HH; Matsui C; Abe T; Watashi K; Wakita T; Suzuki T; Okamoto T; Matsuura Y; Mizokami M; Shoji I; Hotta H
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567989
[TBL] [Abstract][Full Text] [Related]
39. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
[TBL] [Abstract][Full Text] [Related]
40. DDB1 Stimulates Viral Transcription of Hepatitis B Virus via HBx-Independent Mechanisms.
Kim W; Lee S; Son Y; Ko C; Ryu WS
J Virol; 2016 Nov; 90(21):9644-9653. PubMed ID: 27535046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]